Market Overview

Cerulean Pharma (CERU) Staggers as Loss Promised

Share:

Cerulean Pharma Inc (NASDAQ: CERU) shares slid 2.6% to 82 cents, as the company is projected to post a quarterly loss at $0.34 per share on revenue of $5.00 million. Share volume was 386,000, compared to an all-day average of 4.1 million